Dr. Nicholas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Anthony Peter Nicholas, MD, PhD, based in Birmingham, AL, is a neurologist with a subspecialty in movement disorders. He completed his medical education at the University of Texas Medical Branch School of Medicine, after earning a PhD in Anatomy and following a residency in Neurology at the University of Alabama Medical Center. His clinical expertise includes tremor disorders, including Parkinson's disease, and movement disorders such as spasmodic torticollis. Dr. Nicholas has been involved in clinical trials and has numerous publications in peer-reviewed journals, highlighting his research on Parkinson's disease and the role of peptidylarginine deiminases in various conditions. Notably, he has been recognized numerous years as a Regional Top Doctor by Castle Connolly.
Education & Training
- University of Alabama Medical CenterResidency, Neurology, 1993 - 1996
- Physicians Medical Center CarrawayInternship, Transitional Year, 1992 - 1993
- University of Texas Medical Branch School of MedicineClass of 1990
- Graduate School of Biomedical SciencesPhD, Anatomy, 1982 - 1987
Certifications & Licensure
- AL State Medical License 1995 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly
Clinical Trials
- Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 123 citationsTrial of Prasinezumab in Early-Stage Parkinson's Disease.Gennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, Maddalena Marchesi, Tanya Simuni
The New England Journal of Medicine. 2022-08-04 - 12 citationsThe emerging postural instability phenotype in idiopathic Parkinson disease.Frank M Skidmore, William S Monroe, Christopher P Hurt, Anthony P Nicholas, Adam Gerstenecker
NPJ Parkinson's Disease. 2022-03-18 - 55 citationsPeptidylarginine deiminase inhibitors reduce bacterial membrane vesicle release and sensitize bacteria to antibiotic treatmentUchini S. Kosgodage, Paul Matewele, Giulia Mastroianni, Igor Kraev, Dominik Brotherton
Frontiers in Cellular and Infection Microbiology. 2019-06-27
Books/Book Chapters
Grant Support
- Hypertension And Interacting Medullo-Spinal TransmittersNational Heart, Lung, And Blood Institute1991–1992
Professional Memberships
- Member
- Member
- American Neurological AssociationFellow
- Society for NeuroscienceMember
- Movement Disorders SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: